✦ LIBER ✦

Prognostic factors in patients with localised tumor of the Ewing family (ET). Update of the EW88 study of the French Society of Pediatric Oncology (SFOP)

✍ Scribed by Oberlin, O.; Bui, B.N.; Philip, T.; Portas, M.; Mechinaud, F.; Babin Boilletot, A.; Michon, J.

Book ID: 123449021
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 160 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81739-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does myeloablative BuMel therapy improve

Does myeloablative BuMel therapy improve survival of poor-risk localized tumor of the Ewing family (ET)? Experience of the French Society of Pediatric Oncology (SFOP)

✍ Oberlin, O.; Hartmann, O.; Bergeron, C.; Rubie, H.; Baranzelli, M.C.; Boutard, P 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 179 KB

High-dose busulfan + melphalan (BuMel) w

High-dose busulfan + melphalan (BuMel) with autologous stem cell support for metastatic Ewing's tumor (ET). The experience of the French Society of Pediatric Oncology, EW91 study

✍ Oberlin, O.; Maincent, K.; Michon, J.; Bergeron, C.; Rubie, H.; Plantaz, D.; Roc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Prognostic factors and clinical outcome

Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology

✍ Erkan Arpaci, Tarkan Yetisyigit, Metin Seker, Dogan Uncu, Ummugul Uyeturk, Berna 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 360 KB

Initial chemotherapy including ifosfamid

Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results A protocol of the French Pediatric Oncology Society (SFOP)

✍ F. Deméocq; O. Oberlin; E. Benz-Lemoine; A. Boilletot; J. C. Gentet; J. M. Zucke 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 271 KB

Phase II study of ifosfamide in childhoo

Phase II study of ifosfamide in childhood brain tumors: A report by the French society of pediatric oncology (SFOP)

✍ Chastagner, Pascal ;Sommelet-Olive, Danièle ;Kalifa, Chantal ;Brunat-Mentigny, M 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

## Abstract Forty‐two evaluable pediatric patients with a variety of recurrent primary brain tumors participated in a phase II ifosfamide trial. Their mean age was 10 years. All patients were treated with ifosfamide, 3 g/m^2^/day for 2 days every 2 weeks. Response was assessed on clinical and radio

The changing place of radiation-therapy

The changing place of radiation-therapy (RT) in the management of localized Ewing's sarcoma (ES). Results of a cooperative study conducted by the French society of pediatric oncology (SFOP)

✍ J.L. Habrand; D. Pontvert; O. Oberlin; P. Lambin; M. Lacroze; P. Bey; M. Caudry; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 135 KB